Tolerability of integrase inhibitors in a real-life setting

More toxicity stops with elvitegravir than other integrase inhibitors HIV patients at a Barcelona university clinic quit taking elvitegravir less often than raltegravir or dolutegravir in the first year of therapy . But discontinuations for toxicity proved most frequent in people starting elvitegravir in this 1091-patient ...

September 27, 2016

NICE says yes to another hepatitis C drug

A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in the NHS. NICE has published new draft guidance which recommends sofosbuvir-velpatasvir – an anti-viral drug that offers patients with chronic hepatitis C a potential cure. Sofosbuvir-velpatasvir – a tablet taken ...

September 27, 2016

Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zurich ...

September 27, 2016

100% SVR12 reported in the 6-week and 8-week cohorts in Phase 2 trial evaluating odalasvir, AL-335, and simeprevir for genotype 1 treatment-naïve HCV

Achillion announces 100% SVR12 in the 6-week and 8-week cohorts in Janssen’s Phase 2 trial evaluating the triple combination treatment tegimen including odalasvir, AL-335, and simeprevir for genotype 1 treatment-naïve HCV – ePoster presented at the EASL / AASLD Special Conference: New Perspectives in Hepatitis C ...

September 27, 2016

EATG General Assembly in Sofia 23-25 September 2016

The European AIDS Treatment Group is holding its general assembly in Sofia, Bulgaria this weekend of 23-25 September 2016. More than 70 people gathered in the posh but comfortable Sofia Hotel Balkan to discuss the successes and achievements, and also the failures, of the organisation ...

September 24, 2016

Ban calls for continued efforts to secure equal rights for LGBT community

21 September 2016 – United Nations Secretary-General Ban Ki-moon today urged the international community to continue working for equal rights and fair treatment for lesbian, gay, bisexual and transgender (LGBT) people, reiterating the UN’s commitment to securing their human rights. “I will always fight for the ...

September 22, 2016

Renal function declines with HIV PrEP

Renal function declines associated with HIV preexposure prophylaxis (PrEP) are more likely with increasing age and decreasing baseline creatinine clearance, according to a new study. “This is one of the first studies to systematically study predictors of renal decline on tenofovir disoproxil fumarate/emtricitabine (TDF/FTC)-based PrEP in ...

September 22, 2016

At UN, global leaders commit to act on antimicrobial resistance

Collective effort to address a challenge to health, food security, and development 21 September 2016 | NEW YORK – World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines. Antimicrobial resistance (AMR) happens when bacteria, viruses, ...

September 21, 2016

After the Russian Parliament Elections: what to expect?

After the recent elections to the State Duma in Russia last Sunday, it became clear that the legislative strategy of the Russian Parliament regarding civil society is unlikely to change and civil society in Russia will continue to face obstacles. In recent months we have ...

September 21, 2016

OptTEST meeting in Athens – Program now available

The Greek Association of People Living with HIV (PLWH) “Positive Voice” and the “HIV in Europe”, OptTEST project (Optimising testing and linkage to care for HIV across Europe) jointly organise the conference “Linkage to and retention in care: experiences from Europe and Greece and challenges ...

September 21, 2016